Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2005
Bone disease and HIV infectionValerianna Amorosa, Pablo Tebas
The Journal of Infectious Diseases|September 1, 2007
Is it time to rethink the expanded-access programs for HIV infection?Valerianna Amorosa, Pablo Tebas
Current Opinion in HIV and AIDS|July 18, 2015
Simplified diagnostic monitoring for hepatitis C, in the new era of direct-acting antiviral treatmentJennifer Cohn, Teri Roberts, Valerianna Amorosa, et al.
Journal of the American Academy of Dermatology|February 14, 2012
Low prevalence of necrolytic acral erythema in patients with chronic hepatitis C virus infectionBrian A Raphael, Zachariah L Dorey-Stein, Jason Lott, et al.
Otolaryngologic Clinics of North America|July 21, 2023
Skull Base Osteomyelitis: Historical Perspective, Diagnosis and Management UpdateMickie Hamiter, Valerianna Amorosa, Katherine Belden, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|May 10, 2020
Factors Associated With Central Line-Associated Bloodstream Infections in a Cohort of Adult Home Parenteral Nutrition PatientsZhigang Xue, Rachel Coughlin, Valerianna Amorosa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2005
A tale of 2 epidemics: the intersection between obesity and HIV infection in PhiladelphiaValerianna Amorosa, Marie Synnestvedt, Robert Gross, et al.
AIDS (London, England)|September 12, 2008
The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysisSamir K Gupta, Susan L Rosenkranz, Yoninah S Cramer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2020
Mitigation of a Coronavirus Disease 2019 Outbreak in a Nursing Home Through Serial Testing of Residents and StaffDaniel J Escobar, Maria Lanzi, Pouné Saberi, et al.
The Journal of Infectious Diseases|September 18, 2013
Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b studyMark S Sulkowski, Minhee Kang, Roy Matining, et al.
Pageof 2